Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products

Recent studies have demonstrated that the plasma soluble receptor for advanced glycation end-products (sRAGE) play a major role in developing macrovascular complications of type 2 diabetes, including peripheral arterial occlusion disease (PAOD). Cilostazol is an antiplatelet, antithrombotic agent, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jhih-Syuan, Chuang, Tsung-Ju, Chen, Jui-Hung, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Lin, Tsung-Kun, Hsiao, Fone-Ching, Hung, Yi-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512567/
https://www.ncbi.nlm.nih.gov/pubmed/25666934
http://dx.doi.org/10.1007/s12020-015-0545-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512567/
https://www.ncbi.nlm.nih.gov/pubmed/25666934
http://dx.doi.org/10.1007/s12020-015-0545-6

Ejemplares similares